"a healthy 28-year-old, a little overweight but with no other health conditions."
Very sad indeed.
-
As of today ICMag has his own Discord server. In this Discord server you can chat, talk with eachother, listen to music, share stories and pictures...and much more. Join now and let's grow together! Join ICMag Discord here! More details in this thread here: here.
Have You Been Vaccinated?
- Thread starter Tudo
- Start date
"a healthy 28-year-old, a little overweight but with no other health conditions."
Very sad indeed.
elevated blood glucose levels seem to be one unifying characteristic of bad covid infections and bad outcomes ... get healthy people! unhealthy people (you know which 70% you are) are imperiling my health and the health of the other non-overweight/non-obese 30%.
graphene is a single layer of carbon atoms arranged in a hexagonal sheet...it is possible to bend that sheet into a form with magnetic properties
Maybe that’s possible in the world that YOU live in.
What about in the FANTASTIC VOYAGE world?
Is it possible to take sheets of graphene and bend them into this magnetic form, and then inject it inside of the body?
I would imagine these folded graphene sheets would have to be at least as big as the Gates-keeper chips that were already included in the virus.
clearly bill gates is a tech wizard,i mean look at how functional the various iterations of windows are...so obviously he can mass manufacture things that don't exist yet...
side note,i always know where my spoon is now!
clearly bill gates is a tech wizard,i mean look at how functional the various iterations of windows are...so obviously he can mass manufacture things that don't exist yet...
side note,i always know where my spoon is now!
i've always bought my unobtanium from Bill. only supplier i know of...stuff makes great risers for bows.
Small core group at CDC holds patents on several of the newer vaccines.
They have managed to bury a lot of bunkum and accrue an ungodly amount of money, and with it power.
The concept of public service got very twisted within this very small group at the CDC.
Do not expect to see anything come of this, but do find it of interest, and thought it well worth sharing.
https://prn.fm/progressive-commentary-hour-07-21-21/
They have managed to bury a lot of bunkum and accrue an ungodly amount of money, and with it power.
The concept of public service got very twisted within this very small group at the CDC.
Do not expect to see anything come of this, but do find it of interest, and thought it well worth sharing.
https://prn.fm/progressive-commentary-hour-07-21-21/
'New data suggests that fully vaccinated individuals are not just contracting COVID, but could be carrying higher levels of virus than previously understood, facilitating spread, my NBC News colleagues are reporting.' - Ken Dilanian (@KenDilanianNBC)
Should you be wearing a mask again? Here’s a map of the Covid hot spots subject to the CDC’s new guidance
https://www.cnbc.com/2021/07/28/her...t-spots-under-the-cdcs-new-mask-guidance.html
County health dept just reissued mask regulations.
Appears to link back to : https://virological.org/t/viral-inf...ak-caused-by-the-delta-sars-cov-2-variant/724
https://www.cnbc.com/2021/07/28/her...t-spots-under-the-cdcs-new-mask-guidance.html
County health dept just reissued mask regulations.
Appears to link back to : https://virological.org/t/viral-inf...ak-caused-by-the-delta-sars-cov-2-variant/724
Better worry about the vax, not a mask. Besides, foochie said they were no good. Did he change his mind again?
https://www.eutimes.net/2021/06/fir...y-organ-of-body-infested-with-spike-proteins/
https://www.eutimes.net/2021/06/fir...y-organ-of-body-infested-with-spike-proteins/
That is not what your link attached to, not that it would really make any difference whatsoever.
moose eater
Well-known member
I believe 52% of persons eligible to be vaccinated in Alaska have received their 2 jabs, 57% have had at least 1 shot, and the others are the majority in what is now a progression in rising numbers of new infections, to be followed by hospitalizations and mortality.
This past week-end, from July 23-25, we had 562 new confirmed infections.
June 17 we had 10 persons, statewide, in the hospital for C-19. July 21 we had 70, and July 23, we had 80.
See a pattern with the 'opening up'?
And the vast majority of those represented in those stats, are the unvaccinated.
clearly bill gates is a tech wizard,i mean look at how functional the various iterations of windows are...so obviously he can mass manufacture things that don't exist yet...
side note,i always know where my spoon is now!
Windows is a miracle, or a copy of one anyway. When you’re on the cutting edge of technology, you’re shooting in the dark. You make it up as you go. We condemn genius for not being genius enough. We expect 100% while stumbling over the remote control. Trying to decide between the Lone Ranger and Happy Days.
Curt was ,in the words of Pelosi, a moron. The facts are out there. He choose to ignore them out of self chosen stupidity. Hopefully he didn’t take anybody with him.
A blood marker predicts who gets ‘breakthrough’ COVID
Real-world evidence from a medical centre links high levels of potent antibodies after vaccination to a reduced risk of infection.
https://www.nature.com/articles/d41586-021-02096-3
People fully vaccinated against COVID-19 are less likely to become infected with the coronavirus if they have relatively high levels of virus-blocking antibodies, according to a study of thousands of health-care workers who received the Pfizer–BioNTech jab[SUP]1[/SUP].
The analysis adds to a growing body of evidence that a person’s levels of ‘neutralizing’ antibodies, which block SARS-CoV-2 from infecting cells, predict whether that person will become infected.
A robust predictive marker, known as a correlate of protection, could help regulators to approve new vaccines without requiring large clinical trials. It could also help them to assess the need for booster shots to guard against emerging viral variants. The study “is an important step in further validating the use of neutralization titre as a correlate of protection”, says Miles Davenport, an immunologist at the University of New South Wales in Sydney, Australia.
When SARS-CoV-2 breaks through
The study, published in The New England Journal of Medicine on 28 July, draws on data from almost 11,500 fully vaccinated health-care workers at Sheba Medical Center near Tel Aviv, Israel. Extensive testing between late January and late April 2021 identified 39 workers who had become infected with SARS-CoV-2 despite being fully vaccinated. All had mild symptoms or none at all, but 19% still had some symptoms 6 weeks after diagnosis.
For 22 of the 39 workers with ‘breakthrough’ infections, the authors were able to obtain antibody measurements taken either on the day the infections were detected or in the week before. The researchers also examined data from 104 fully vaccinated workers who matched infected workers for factors such as age but who did not get infected. Comparison showed that levels of neutralizing antibodies were lower among those who got infected — providing the first direct evidence of this effect, says Davenport.
The results bolster earlier data collected during clinical trials of the Oxford–AstraZeneca vaccine. Analysis of those data also showed a link between higher levels of neutralizing antibodies and a lower likelihood of breakthrough infection[SUP]2[/SUP]. But the difference in antibody levels between trial participants who had breakthrough infections and those who didn’t was not statistically significant.
The latest study does have drawbacks. It is based on a small number of cases among young and healthy adults, which limits its application, says Andrew Fiore-Gartland, a biostatistician at the Fred Hutchinson Cancer Research Center in Seattle, Washington. More studies from vaccine trials are expected soon, he says.
And the analysis does not provide a specific level of antibodies that is associated with protection, say researchers. Such a threshold of protection “is what the field really needs to move forward”, says Fiore-Gartland.
Real-world evidence from a medical centre links high levels of potent antibodies after vaccination to a reduced risk of infection.
https://www.nature.com/articles/d41586-021-02096-3
People fully vaccinated against COVID-19 are less likely to become infected with the coronavirus if they have relatively high levels of virus-blocking antibodies, according to a study of thousands of health-care workers who received the Pfizer–BioNTech jab[SUP]1[/SUP].
The analysis adds to a growing body of evidence that a person’s levels of ‘neutralizing’ antibodies, which block SARS-CoV-2 from infecting cells, predict whether that person will become infected.
A robust predictive marker, known as a correlate of protection, could help regulators to approve new vaccines without requiring large clinical trials. It could also help them to assess the need for booster shots to guard against emerging viral variants. The study “is an important step in further validating the use of neutralization titre as a correlate of protection”, says Miles Davenport, an immunologist at the University of New South Wales in Sydney, Australia.
When SARS-CoV-2 breaks through
The study, published in The New England Journal of Medicine on 28 July, draws on data from almost 11,500 fully vaccinated health-care workers at Sheba Medical Center near Tel Aviv, Israel. Extensive testing between late January and late April 2021 identified 39 workers who had become infected with SARS-CoV-2 despite being fully vaccinated. All had mild symptoms or none at all, but 19% still had some symptoms 6 weeks after diagnosis.
For 22 of the 39 workers with ‘breakthrough’ infections, the authors were able to obtain antibody measurements taken either on the day the infections were detected or in the week before. The researchers also examined data from 104 fully vaccinated workers who matched infected workers for factors such as age but who did not get infected. Comparison showed that levels of neutralizing antibodies were lower among those who got infected — providing the first direct evidence of this effect, says Davenport.
The results bolster earlier data collected during clinical trials of the Oxford–AstraZeneca vaccine. Analysis of those data also showed a link between higher levels of neutralizing antibodies and a lower likelihood of breakthrough infection[SUP]2[/SUP]. But the difference in antibody levels between trial participants who had breakthrough infections and those who didn’t was not statistically significant.
The latest study does have drawbacks. It is based on a small number of cases among young and healthy adults, which limits its application, says Andrew Fiore-Gartland, a biostatistician at the Fred Hutchinson Cancer Research Center in Seattle, Washington. More studies from vaccine trials are expected soon, he says.
And the analysis does not provide a specific level of antibodies that is associated with protection, say researchers. Such a threshold of protection “is what the field really needs to move forward”, says Fiore-Gartland.
Israel offers third shot of Pfizer COVID-19 vaccine to adults at risk
https://www.reuters.com/world/middle...sk-2021-07-11/
JERUSALEM, July 11 (Reuters) - Israel said on Sunday it will begin offering a third dose of Pfizer Inc's (PFE.N) vaccine to adults with weak immune systems but it was still weighing whether to make the booster available to the general public.
The rapid spread of the Delta variant has sent vaccination rates in Israel back up as new infections have risen over the past month from single digits to around 450 a day, and the country has moved to fast-track its next Pfizer shipment.
Health Minister Nitzan Horowitz said that effective immediately, adults with impaired immune systems who had received two doses of the Pfizer vaccine could get a booster shot, with a decision pending on wider distribution.
Pfizer and partner BioNTech SE , the main suppliers in a swift Israeli vaccination rollout that began in December, said on Thursday they will ask U.S. and European regulators within weeks to authorize booster shots.
The two companies cited an increased risk of infection after six months in seeking permission for a third shot.
Drawing criticism from some scientists and officials, the companies did not share the data showing that risk, but said it would soon be made public. They also cited recent Israeli data. read more
"We are examining this issue and we still do not have a final answer," Horowitz, speaking on Kan public radio, said about a booster for the general population in Israel.
"In any case we are administering as of now a third shot to people suffering from immunodeficiency."
About half of the 46 patients presently hospitalised in Israel in severe condition are vaccinated, and the majority are from risk groups, according to the health authorities. About 5.7 million out of Israel 9.3 population has received at leas one dose.
Israel was not going to rush into any decision on booster shots for the general public, Sharon Alroy-Preis, head of public health at the Health Ministry said.
"It's rather complex. We're presently seeing outbreaks largely among children and their parents who weren't necessarily vaccinated in January and February and we need to identify the (statistical) biases," Alroy-Preis told Kan.
It was still unclear, Alroy-Preis added, whether the vaccine was simply less effective against the Delta variant and if illness rates among those vaccinated in January and February were higher than for those who were inoculated later.
SUPPLY GAP
Horowitz said that separately, the health ministry would plug a Pfizer supply gap for ongoing two-dose inoculations of the general adult population by using Moderna Inc (MRNA.O) vaccines already in stock.
Prime Minister Naftali Bennett said in broadcast remarks to his cabinet on Sunday that he has agreed with Pfizer to bring forward the next delivery of doses to Aug 1. The shipment had been widely expected to arrive in September.
There was no immediate response from Pfizer to a request for comment.
https://www.reuters.com/world/middle...sk-2021-07-11/
JERUSALEM, July 11 (Reuters) - Israel said on Sunday it will begin offering a third dose of Pfizer Inc's (PFE.N) vaccine to adults with weak immune systems but it was still weighing whether to make the booster available to the general public.
The rapid spread of the Delta variant has sent vaccination rates in Israel back up as new infections have risen over the past month from single digits to around 450 a day, and the country has moved to fast-track its next Pfizer shipment.
Health Minister Nitzan Horowitz said that effective immediately, adults with impaired immune systems who had received two doses of the Pfizer vaccine could get a booster shot, with a decision pending on wider distribution.
Pfizer and partner BioNTech SE , the main suppliers in a swift Israeli vaccination rollout that began in December, said on Thursday they will ask U.S. and European regulators within weeks to authorize booster shots.
The two companies cited an increased risk of infection after six months in seeking permission for a third shot.
Drawing criticism from some scientists and officials, the companies did not share the data showing that risk, but said it would soon be made public. They also cited recent Israeli data. read more
"We are examining this issue and we still do not have a final answer," Horowitz, speaking on Kan public radio, said about a booster for the general population in Israel.
"In any case we are administering as of now a third shot to people suffering from immunodeficiency."
About half of the 46 patients presently hospitalised in Israel in severe condition are vaccinated, and the majority are from risk groups, according to the health authorities. About 5.7 million out of Israel 9.3 population has received at leas one dose.
Israel was not going to rush into any decision on booster shots for the general public, Sharon Alroy-Preis, head of public health at the Health Ministry said.
"It's rather complex. We're presently seeing outbreaks largely among children and their parents who weren't necessarily vaccinated in January and February and we need to identify the (statistical) biases," Alroy-Preis told Kan.
It was still unclear, Alroy-Preis added, whether the vaccine was simply less effective against the Delta variant and if illness rates among those vaccinated in January and February were higher than for those who were inoculated later.
SUPPLY GAP
Horowitz said that separately, the health ministry would plug a Pfizer supply gap for ongoing two-dose inoculations of the general adult population by using Moderna Inc (MRNA.O) vaccines already in stock.
Prime Minister Naftali Bennett said in broadcast remarks to his cabinet on Sunday that he has agreed with Pfizer to bring forward the next delivery of doses to Aug 1. The shipment had been widely expected to arrive in September.
There was no immediate response from Pfizer to a request for comment.
